Simavita Limited

ASX Appendix 4C for the Quarter Ended June 30, 2015 - Seite 2

Notably, our agreement with MatrixCare to jointly develop an interoperable solution between our SIM™ platform and their electronic health record system, will open doors to significant long term care opportunities for Simavita in the US. In Australia, we have now executed valuable new distribution agreements with Bunzl and HARTMANN which will expand our sales force and our reach in the local market, alongside two trusted and reputable partners."

"More recently, we have negotiated positive changes to our agreement with our US distributor, Medline, and executed agreements with two Canadian parties to commence the sale and distribution of SIM™ in Canada. All of this activity, alongside further foundational activity in Europe, supported by our successful capital raising in April, positions Simavita strongly to enter into what we see as an important new financial year ahead for the Company," Mrs. Lewis added.

For further information, see our website (www.simavita.com) or contact the persons outlined below.

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

The TSX Venture Exchange ("TSX-V") has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this Release.